Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest TomoTherapy Incorporated. Stories

2012-10-26 07:23:50

SUNNYVALE, Calif., Oct. 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, showcased new clinical research on its TomoTherapy(®) System at the 2012 TomoTherapy Asia Pacific Users' Meeting, which was held in conjunction with the Hong Kong Sanatorium & Hospital Scientific Meeting on Radiotherapy and TomoTherapy on September 21-23, 2012 in Hong Kong. The conference brought together approximately 130 TomoTherapy System users from across...

2012-06-21 02:26:43

SUNNYVALE, Calif., June 21, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the company's successes since its acquisition of TomoTherapy Incorporated one year ago and its vision for growth and profitability in the future, as part of a presentation by the company's chief financial officer Derek Bertocci at the Wells Fargo Healthcare Conference in Boston. As part of Accuray's transformative acquisition of TomoTherapy...

2011-06-13 06:30:00

SUNNYVALE, Calif., June 13, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that it has completed its previously announced acquisition of TomoTherapy Incorporated (Nasdaq: TOMO). The combination creates the premier radiation oncology company, offering best-in-class technologies to fight cancer. The combined company is focused on developing, manufacturing and selling personalized, leading-edge treatment solutions that revolve around the patient. "The successful...

2011-06-09 11:23:00

SUNNYVALE, Calif., June 9, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that TomoTherapy shareholders have approved the proposed acquisition of TomoTherapy Incorporated (Nasdaq: TOMO) by Accuray. More than 98 percent of votes cast and 79 percent of shares outstanding were voted in favor of the transaction. The companies anticipate the closing of the transaction will occur within one to two business days, assuming...

2011-05-09 07:30:00

SUNNYVALE, Calif., May 9, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the U.S. Securities and Exchange Commission has declared effective the company's Form S-4 Registration Statement relating to the previously announced acquisition of TomoTherapy Incorporated (Nasdaq: TOMO). The proxy statement/prospectus contained in the registration statement will first be mailed to TomoTherapy shareholders on or about...

2011-04-26 06:00:00

SUNNYVALE, Calif., April 26, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in connection with the previously announced acquisition of TomoTherapy Incorporated (NASDAQ: TOMO). "The satisfaction of this condition represents a significant step toward the completion of the transaction and...

2011-03-07 06:00:00

SUNNYVALE, Calif. and MADISON, Wis., March 7, 2011 /PRNewswire/ -- Accuray (Nasdaq: ARAY), a global leader in the field of radiosurgery, and TomoTherapy Incorporated (Nasdaq: TOMO), creator of advanced radiation therapy solutions for cancer care, today announced that they have signed a definitive agreement under which Accuray will acquire TomoTherapy for $4.80 per share in cash and stock, or a total of approximately $277 million. The transaction combines the best-in-class technologies...

2009-08-26 09:51:00

KANSAS CITY, Mo., Aug. 26 /PRNewswire/ -- Kansas City Cancer Center (KCCC), an affiliate of US Oncology, Inc. which supports the nation's foremost cancer treatment and research network, has treated its first patient with the new TomoTherapy(R) radiation therapy technology at its new KCCC-Shawnee Mission office. KCCC is the only healthcare provider in the greater Kansas City metropolitan area with a TomoTherapy treatment machine - a welcomed new treatment that combines CT imaging with...

2008-10-29 18:00:25

TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Technical University of Munich, Germany, recently welcomed 175 radiation oncology experts from 16 countries to the 'International Conference on the Clinical Use of TomoTherapy'. The two-day event featured 35 technical talks from doctors and physicists. Presentations covered the multiple cancer types clinicians are treating with CT-guided, helical TomoTherapy(SM) and treatment protocols that show promise in gaining improved outcomes...

2008-10-15 18:00:24

TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Grupo IMO of Madrid, Spain, recently hosted a symposium on the clinical use of the Hi-Art(R) treatment system for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). Symposium speakers highlighted the Hi-Art system's inherent suitability for stereotactic procedures with respect to dose conformality and homogeneity; presented clinical work on a variety of intra- and extracranial cases; and discussed future...